Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Return on Equity (2016 - 2025)

Historic Return on Equity for Veracyte (VCYT) over the last 13 years, with Q3 2025 value amounting to 0.02%.

  • Veracyte's Return on Equity rose 300.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.02% for FY2024, which is 900.0% up from last year.
  • Veracyte's Return on Equity amounted to 0.02% in Q3 2025, which was up 300.0% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Veracyte's Return on Equity registered a high of 0.03% during Q1 2025, and its lowest value of 0.09% during Q1 2021.
  • Its 5-year average for Return on Equity is 0.03%, with a median of 0.04% in 2022.
  • As far as peak fluctuations go, Veracyte's Return on Equity plummeted by -400bps in 2023, and later skyrocketed by 900bps in 2024.
  • Quarter analysis of 5 years shows Veracyte's Return on Equity stood at 0.07% in 2021, then surged by 50bps to 0.03% in 2022, then plummeted by -106bps to 0.07% in 2023, then skyrocketed by 129bps to 0.02% in 2024, then increased by 19bps to 0.02% in 2025.
  • Its Return on Equity was 0.02% in Q3 2025, compared to 0.02% in Q2 2025 and 0.03% in Q1 2025.